BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research report report published on Tuesday. The brokerage issued a sell rating on the medical technology company’s stock. BIOLASE Stock Performance NASDAQ:BIOL opened at $0.01 on Tuesday. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94. The firm […]
StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research report report published on Tuesday. The brokerage issued a sell rating on the medical technology company’s stock. BIOLASE Stock Performance NASDAQ:BIOL opened at $0.01 on Tuesday. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94. The firm […]
